Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Hdl Handle:
http://hdl.handle.net/10144/220294
Title:
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Authors:
Blanc, F-X; Sok, T; Laureillard, D; Borand, L; Rekacewicz, C; Nerrienet, E; Madec, Y; Marcy, O; Chan, S; Prak, N; Kim, C; Lak, K K; Hak, C; Dim, B; Sin, C I; Sun, S; Guillard, B; Sar, B; Vong, S; Fernandez, M; Fox, L; Delfraissy, J-F; Goldfeld, A E
Journal:
New England Journal of Medicine
Abstract:
Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.
Affiliation:
Pneumology Unit, Internal Medicine Department, Bicêtre Hospital, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France. xavier.blanc@bct.aphp.fr
Issue Date:
20-Oct-2011
URI:
http://hdl.handle.net/10144/220294
DOI:
10.1056/NEJMoa1013911
PubMed ID:
22010913
Language:
en
ISSN:
1533-4406
Appears in Collections:
TB; HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorBlanc, F-Xen_GB
dc.contributor.authorSok, Ten_GB
dc.contributor.authorLaureillard, Den_GB
dc.contributor.authorBorand, Len_GB
dc.contributor.authorRekacewicz, Cen_GB
dc.contributor.authorNerrienet, Een_GB
dc.contributor.authorMadec, Yen_GB
dc.contributor.authorMarcy, Oen_GB
dc.contributor.authorChan, Sen_GB
dc.contributor.authorPrak, Nen_GB
dc.contributor.authorKim, Cen_GB
dc.contributor.authorLak, K Ken_GB
dc.contributor.authorHak, Cen_GB
dc.contributor.authorDim, Ben_GB
dc.contributor.authorSin, C Ien_GB
dc.contributor.authorSun, Sen_GB
dc.contributor.authorGuillard, Ben_GB
dc.contributor.authorSar, Ben_GB
dc.contributor.authorVong, Sen_GB
dc.contributor.authorFernandez, Men_GB
dc.contributor.authorFox, Len_GB
dc.contributor.authorDelfraissy, J-Fen_GB
dc.contributor.authorGoldfeld, A Een_GB
dc.date.accessioned2012-04-24T14:01:36Z-
dc.date.available2012-04-24T14:01:36Z-
dc.date.issued2011-10-20-
dc.identifier.citationEarlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. 2011, 365 (16):1471-81 N. Engl. J. Med.en_GB
dc.identifier.issn1533-4406-
dc.identifier.pmid22010913-
dc.identifier.doi10.1056/NEJMoa1013911-
dc.identifier.urihttp://hdl.handle.net/10144/220294-
dc.description.abstractTuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to The New England Journal of Medicine's open access policy.en_GB
dc.subject.meshAIDS-Related Opportunistic Infectionsen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-Retroviral Agentsen_GB
dc.subject.meshAntitubercular Agentsen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshDrug Administration Scheduleen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshFollow-Up Studiesen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshKaplan-Meier Estimateen_GB
dc.subject.meshMaleen_GB
dc.subject.meshTuberculosisen_GB
dc.subject.meshViral Loaden_GB
dc.titleEarlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.en
dc.contributor.departmentPneumology Unit, Internal Medicine Department, Bicêtre Hospital, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France. xavier.blanc@bct.aphp.fren_GB
dc.identifier.journalNew England Journal of Medicineen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.